Stockholders' Deficit (Details)		1 Months Ended		12 Months Ended
	Jan. 13, 2010 USD ($) $ / shares shares	Feb. 13, 2018 Director $ / shares shares	Dec. 22, 2009 USD ($) $ / shares shares	Dec. 31, 2011 shares	Dec. 31, 2010 shares	Dec. 31, 2018 $ / shares shares	Dec. 31, 2017 $ / shares shares	Jan. 22, 2008 $ / shares shares
Stockholders' Deficit (Textual)
Authorized capital stock								120,000,000
Preferred stock, shares authorized								20,000,000
Preferred stock, par value | $ / shares								$ 0.001
Common stock, shares authorized						100,000,000	100,000,000	100,000,000
Common stock, par value | $ / shares						$ 0.001	$ 0.001	$ 0.001
VP [Member]
Stockholders' Deficit (Textual)
Shares price per share | $ / shares		$ 0.06
Issued shares of common stock		12,000
CFO [Member]
Stockholders' Deficit (Textual)
Shares price per share | $ / shares		$ 0.06
Issued shares of common stock		40,000
Directors [Member]
Stockholders' Deficit (Textual)
Shares price per share | $ / shares		$ 0.06
Issued shares of common stock		200,000
Number of individuals | Director		4
Private placement [Member]
Stockholders' Deficit (Textual)
Shares price per share | $ / shares	$ 1.32		$ 1.32
Number of shares sold in private placement, shares	124,025		124,025
Number of shares deposited in escrow				1,240,250	1,240,250
Private placement expense | $	$ 298,000		$ 298,000
Term of warrants	5 years		5 years
Series B Preferred Stock [Member] | Private placement [Member]
Stockholders' Deficit (Textual)
Shares price per share | $ / shares	$ 1.30		$ 1.30
Number of shares sold in private placement, shares	2,480,500		2,480,500
Aggregate purchase price of shares | $	$ 2,976,600		$ 2,976,600
Term of warrants	5 years		5 years
Warrants issued to purchase of common stock	992,000		992,000